Cracking the Code of Multi-Indication Drugs
Moving Beyond Traditional Data Sources
Multi-indication drugs open new possibilities for pharmaceutical marketing but also bring unique challenges. Approved for multiple conditions, these treatments require a targeted, data-driven strategy to unlock their full potential across diverse therapeutic areas. In Japan, traditional sales and distribution data fall short in revealing specific usage patterns, risking missed opportunities and inefficient resource allocation. A more nuanced approach is essential to capture untapped potential and enhance patient access.
Taking Brand Intelligence From National to Hyperlocal
Maximizing Opportunities and Mitigating Risks with Prospection AI and Facility Insights
The ability to see and act on facility-level insights is not just an advantage – it’s a necessity. With Prospection AI and Facility Insights, pharmaceutical companies are equipped to treat patients with greater precision and confidence, driving both business success and improved patient outcomes.
Unlocking US Market Potential
How Patient-centric Intelligence Guides Emerging Biotech and Medical Device Companies
Patient-centric intelligence (PCI) offers Australian biotech and medical device companies a powerful tool for navigating the US healthcare market. Discover how PCI can unlock market potential, mitigate risks, and strengthen pitches to partners and investors.
Breaking Down Silos
How Patient-Centric Intelligence (PCI) Platforms Can Boost Collaborative Brand Management
Learn how Patient-Centric Intelligence (PCI) platforms can enhance collaborative brand management in the pharmaceutical industry. By integrating data and fostering cross-functional teamwork, PCI platforms empower teams to make informed decisions that improve patient outcomes and optimise brand performance. Discover how breaking down silos can lead to more effective, patient-centric strategies.
Prospection CEO Daniel West on Patient-Centric Intelligence and Category Creation
Prospection’s CEO Daniel West discusses the journey to build the future of patient-centric intelligence, unpacking the role that category design plays in defining business strategy and strengthening the company’s goal to address care and share leaks in pharma. Listen to the podcast to learn more.
Navigating the Complexity of Patient Data: Why Pharma Needs Specialized Intelligence Platforms
Generic analytics tools often fail to address the complexity of patient data in pharma. Learn why putting specialized intelligence platforms in the hands of analytics as well as commercial teams is essential for generating actionable insights that drive better patient outcomes and commercial success.
RWD is not Insights—PCI Transforms Patient Understanding
RWD alone isn’t enough. To truly understand patients and drive meaningful improvements, you need PCI. Find out why RWD falls short and how PCI bridges the gap, providing pharmaceutical companies with the insights they need.
Q&A with Eiichi Naka: Patient-centricity to Drive Outcomes for Rare Disease
Mr. Eiichi Naka, a senior pharma leader with 40 years experience, discusses patient-centric PSPs and the impact of AI in driving outcomes in rare disease.
Prospection wins APAC Insider 2024 awards!
Prospection has won two prestigious awards from APAC Insider. These achievements reflect our dedication to improving healthcare through cutting-edge technology.
5 Questions with Ipsen’s Nicholas Phillips: AI and Adopting a Patient-centric Intelligence Platform
Discover how AI and patient-centric intelligence are transforming pharma’s approach to commercial strategy. Ipsen’s Nicholas Phillips shares insights on leveraging AI for data-driven decision-making and improved patient outcomes.
Better brand planning with analytics teams and PCI
Enhancing Collaboration and Driving Better Outcomes
Successful brand planning is the product of great synergy between analytics and commercial teams. Patient-centric intelligence (PCI) has emerged as a game-changer, bridging the gap between these teams and enabling data-driven decision-making. Discover how PCI can enhance collaboration, improve brand performance, and ultimately drive better patient outcomes.
Download the Brand Planning Guide to Connect Care at the Core with Patient-centric Intelligence
Discover the power of patient-centric intelligence in our latest whitepaper, “Connect Care at the Core: A Brand Planning Guide.” This comprehensive resource explores how leveraging real-world insights can transform your brand planning process, uplifting market share and patient care.
